AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
NEOADJUVANT CHEMORADIOTHERAPY FOR OPERABLE BREAST-CANCER - PRELIMINARY-RESULTS OF AN ONGOING PHASE-II STUDY
Authors: PACINI P AUSILICEFARO GP NARDONE L RINALDINI M IRTELLI L MENICHELLI C BAGNOLI R RUBAGOTTI A BOCCARDO F
Citation: P. Pacini et al., NEOADJUVANT CHEMORADIOTHERAPY FOR OPERABLE BREAST-CANCER - PRELIMINARY-RESULTS OF AN ONGOING PHASE-II STUDY, European journal of cancer, 34, 1998, pp. 264-264
REVIEW OF ITALIAN BREAST-CANCER STUDY-GROUP (GROCTA) TRIALS
Authors: BOCCARDO F RUBAGOTTI A AMOROSO D
Citation: F. Boccardo et al., REVIEW OF ITALIAN BREAST-CANCER STUDY-GROUP (GROCTA) TRIALS, European journal of cancer, 34, 1998, pp. 44-44
VACOP-B VERSUS VACOP-B PLUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP
Authors: SANTINI G SALVAGNO L LEONI P CHISESI T DESOUZA C SERTOLI MR RUBAGOTTI A CONGIU AM CENTURIONI R OLIVIERI A TEDESCHI L VESPIGNANI M NATI S SORACCO M PORCELLINI A CONTU A GUARNACCIA C PESCOSTA N MAJOLINO I SPRIANO M VIMERCATI R ROSSI E ZAMBALDI G MANGONI L ENDRIZZI L SILENI VC MIGGIANO MC MARINO G DAMASIO E RIZZOLI V
Citation: G. Santini et al., VACOP-B VERSUS VACOP-B PLUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 16(8), 1998, pp. 2796-2802
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
BICALUTAMIDE(B) MONOTHERAPY VERSUS FLUTAMIDE(F) PLUS GOSERELIN(G) IN PROSTATE-CANCER (CA) PATIENTS (PTS) - PRELIMINARY-RESULTS OF AN ITALIAN PROSTATE-CANCER GROUP (PONCAP) STUDY
Authors: DITONNO P BATTAGLIA M SELVAGGI FP PONTI UD BARICHELLO M COMERI GC CONTI G PORTOGHESE F MONTEFIORE F FERRARIS V LILLIU S DAMMINO S SPANO G RUBAGOTTI A BOCCARDO F
Citation: P. Ditonno et al., BICALUTAMIDE(B) MONOTHERAPY VERSUS FLUTAMIDE(F) PLUS GOSERELIN(G) IN PROSTATE-CANCER (CA) PATIENTS (PTS) - PRELIMINARY-RESULTS OF AN ITALIAN PROSTATE-CANCER GROUP (PONCAP) STUDY, The Journal of urology, 159(5), 1998, pp. 490-490
LACK OF EFFECTIVENESS OF ADJUVANT ALTERNATING CHEMOTHERAPY IN NODE-POSITIVE, ESTROGEN-RECEPTOR-NEGATIVE PREMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY
Authors: BOCCARDO F RUBAGOTTI A AMOROSO D PERROTTA A SISMONDI P FARRIS A MESITI M GALLO L PACINI P VILLA E AGOSTARA B GENTA F DESANCTIS C SCOTTO T SPADARO P BUCCARAN G CAPPELLINI M BOLOGNESI A ALDRIGHETTI D TRAINA A SCHIEPPATI G SASSI M MUSTACCHI G BENETTI GP BANDUCCI S GATTI C ROLFO F IACOBELLI S IRTELLI L
Citation: F. Boccardo et al., LACK OF EFFECTIVENESS OF ADJUVANT ALTERNATING CHEMOTHERAPY IN NODE-POSITIVE, ESTROGEN-RECEPTOR-NEGATIVE PREMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY, Cancer investigation, 15(6), 1997, pp. 505-512
A RANDOMIZED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN LOCALLY ADVANCED BREAST-CANCER
Authors: BALDINI E GARDIN G GIANNESSI P BREMA F CAMORRIANO A CARNINO F NASO C PASTORINO G PRONZATO P ROSSO R RUBAGOTTI A TORRETTA G CONTE PF
Citation: E. Baldini et al., A RANDOMIZED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN LOCALLY ADVANCED BREAST-CANCER, Tumori, 83(5), 1997, pp. 829-833
INTRAPERITONEAL CARBOPLATIN WITH OR WITHOUT INTERFERON-ALPHA IN ADVANCED OVARIAN-CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE AT 2ND LOOK - A PROSPECTIVE RANDOMIZED TRIAL OF 111 PATIENTS
Authors: BRUZZONE M RUBAGOTTI A GADDUCCI A CATSAFADOS E FOGLIA G BRUNETTI I GIANNESSI PG CARNINO F ISKRA L ROSSO R MARTONI A PANNUTI F DELISI V MALTONI R RIDOLFI R MAMMOLITI S GALLO L BOCCARDO F RAGNI N CONTE PF
Citation: M. Bruzzone et al., INTRAPERITONEAL CARBOPLATIN WITH OR WITHOUT INTERFERON-ALPHA IN ADVANCED OVARIAN-CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE AT 2ND LOOK - A PROSPECTIVE RANDOMIZED TRIAL OF 111 PATIENTS, Gynecologic oncology, 65(3), 1997, pp. 499-505
12-YEAR FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING CISPLATIN AND CYCLOPHOSPHAMIDE WITH CISPLATIN, DOXORUBICIN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: GADDUCCI A BRUZZONE M CARNINO F RAGNI N RUBAGOTTI A CONTE PF
Citation: A. Gadducci et al., 12-YEAR FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING CISPLATIN AND CYCLOPHOSPHAMIDE WITH CISPLATIN, DOXORUBICIN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER, International journal of gynecological cancer, 6(4), 1996, pp. 286-290
CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL OF THE GRUPPO-ONCOLOGICO-NORD-OVEST (GONO)
Authors: CONTE PF BALDINI E GARDIN G PRONZATO P AMADORI D CARNINO F MONZEGLIO C GENTILINI P GALLOTTI P DEMICHELI R VENTURINI M RUBAGOTTI A ROSSO R
Citation: Pf. Conte et al., CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL OF THE GRUPPO-ONCOLOGICO-NORD-OVEST (GONO), Annals of oncology, 7(5), 1996, pp. 487-490
RISK OF NEW PRIMARIES AFTER CHEMOTHERAPY AND OR TAMOXIFEN TREATMENT FOR EARLY BREAST-CANCER/
Authors: RUBAGOTTI A PERROTTA A CASELLA C BOCCARDO F
Citation: A. Rubagotti et al., RISK OF NEW PRIMARIES AFTER CHEMOTHERAPY AND OR TAMOXIFEN TREATMENT FOR EARLY BREAST-CANCER/, Annals of oncology, 7(3), 1996, pp. 239-244
HIGH-DOSE VERSUS LOW-DOSE CISPLATIN IN COMBINATION WITH CYCLOPHOSPHAMIDE AND EPIDOXORUBICIN IN SUBOPTIMAL OVARIAN-CANCER - A RANDOMIZED STUDY OF THE GRUPPO ONCOLOGICO NORD-OVEST
Authors: CONTE PF BRUZZONE M CARNINO F GADDUCCI A ALGERI R BELLINI A BOCCARDO F BRUNETTI I CATSAFADOS E CHIARA S FOGLIA G GALLO I ISKRA L MAMMOLITI S PARODI G RAGNI N ROSSO R RUGIATI S RUBAGOTTI A
Citation: Pf. Conte et al., HIGH-DOSE VERSUS LOW-DOSE CISPLATIN IN COMBINATION WITH CYCLOPHOSPHAMIDE AND EPIDOXORUBICIN IN SUBOPTIMAL OVARIAN-CANCER - A RANDOMIZED STUDY OF THE GRUPPO ONCOLOGICO NORD-OVEST, Journal of clinical oncology, 14(2), 1996, pp. 351-356
RISK OF 2ND MALIGNANCIES FOLLOWING ADJUVANT CHEMO (CT) A O TAMOXIFEN (T) THERAPY/
Authors: BOCCARDO F RUBAGOTTI A PERROTTA A CASELLA C AMOROSO D
Citation: F. Boccardo et al., RISK OF 2ND MALIGNANCIES FOLLOWING ADJUVANT CHEMO (CT) A O TAMOXIFEN (T) THERAPY/, European journal of cancer, 31A, 1995, pp. 50-50
RANDOMIZED COOPERATIVE STUDY OF PERIOPERATIVE CHEMOTHERAPY IN BREAST-CANCER
Authors: SERTOLI MR BRUZZI P PRONZATO P QUEIROLO P AMOROSO D DELMASTRO L VENTURINI M VIGANI A BERTELLI G CAMPORA E BOCCARDO F MONZEGLIO C PAGANINI E PASTORINO G CANAVESE G CATTURICH A CAFIERO F VECCHIO C MICCOLI P RUBAGOTTI A ROSSO R
Citation: Mr. Sertoli et al., RANDOMIZED COOPERATIVE STUDY OF PERIOPERATIVE CHEMOTHERAPY IN BREAST-CANCER, Journal of clinical oncology, 13(11), 1995, pp. 2712-2721
PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH INTERLEUKIN-2 AND INTERFERON-ALPHA
Authors: CANOBBIO L RUBAGOTTI A MIGLIETTA L CANNATA D CUROTTO A AMOROSO D BOCCARDO F
Citation: L. Canobbio et al., PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH INTERLEUKIN-2 AND INTERFERON-ALPHA, Journal of cancer research and clinical oncology, 121(12), 1995, pp. 753-756
OVARIAN ABLATION VERSUS GOSERELIN WITH OR WITHOUT TAMOXIFEN IN PRE-PERIMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC ITALIAN STUDY
Authors: BOCCARDO F RUBAGOTTI A PERROTTA A AMOROSO D BALESTRERO M DEMATTEIS A ZOLA P SISMONDI P FRANCINI G PETRIOLI R SASSI M PACINI P GALLIGIONI E
Citation: F. Boccardo et al., OVARIAN ABLATION VERSUS GOSERELIN WITH OR WITHOUT TAMOXIFEN IN PRE-PERIMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC ITALIAN STUDY, Annals of oncology, 5(4), 1994, pp. 337-342
MACOP-B VERSUS PROMACE-MOPP IN THE TREATMENT OF ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP
Authors: SERTOLI MR SANTINI G CHISESI T CONGIU AM RUBAGOTTI A CONTU A SALVAGNO L COSER P PORCELLINI A VESPIGNANI M CAPNIST G ROSSI E MANGONI L FABRIS P VINANTE O TEDESCHI L ENDRIZZI L MIGLIO LP PERROTTA A ROSSO R DAMASIO E RIZZOLI V
Citation: Mr. Sertoli et al., MACOP-B VERSUS PROMACE-MOPP IN THE TREATMENT OF ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 12(7), 1994, pp. 1366-1374
PROPHYLAXIS OF SUPERFICIAL BLADDER-CANCER WITH MITOMYCIN OR INTERFERON ALFA-2B - RESULTS OF A MULTICENTRIC ITALIAN STUDY
Authors: BOCCARDO F CANNATA D RUBAGOTTI A GUARNERI D DECENSI A CANOBBIO L CUROTTO A MARTORANA G PEGORARO C SELVAGGI F SALVIA G COMERI G BONO A BORELLA T GIULIANI L
Citation: F. Boccardo et al., PROPHYLAXIS OF SUPERFICIAL BLADDER-CANCER WITH MITOMYCIN OR INTERFERON ALFA-2B - RESULTS OF A MULTICENTRIC ITALIAN STUDY, Journal of clinical oncology, 12(1), 1994, pp. 7-13
ONDANSETRON AND DEXAMETHASONE VERSUS STANDARD COMBINATION ANTIEMETIC THERAPY - A RANDOMIZED TRIAL FOR THE PREVENTION OF ACUTE AND DELAYED EMESIS INDUCED BY CYCLOPHOSPHAMIDE DOXORUBICIN CHEMOTHERAPY AND MAINTENANCE OF ANTIEMETIC EFFECT AT SUBSEQUENT COURSES
Authors: CAMPORA E GIUDICI S MERLINI L RUBAGOTTI A ROSSO R
Citation: E. Campora et al., ONDANSETRON AND DEXAMETHASONE VERSUS STANDARD COMBINATION ANTIEMETIC THERAPY - A RANDOMIZED TRIAL FOR THE PREVENTION OF ACUTE AND DELAYED EMESIS INDUCED BY CYCLOPHOSPHAMIDE DOXORUBICIN CHEMOTHERAPY AND MAINTENANCE OF ANTIEMETIC EFFECT AT SUBSEQUENT COURSES, American journal of clinical oncology, 17(6), 1994, pp. 522-526
HIGH-RISK EARLY-STAGE OVARIAN-CANCER - RANDOMIZED CLINICAL-TRIAL COMPARING CISPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS WHOLE ABDOMINAL RADIOTHERAPY
Authors: CHIARA S CONTE P FRANZONE P ORSATTI M BRUZZONE M RUBAGOTTI A ODICINO F RUGIATI S CARNINO F ROSSO R RAGNI N
Citation: S. Chiara et al., HIGH-RISK EARLY-STAGE OVARIAN-CANCER - RANDOMIZED CLINICAL-TRIAL COMPARING CISPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS WHOLE ABDOMINAL RADIOTHERAPY, American journal of clinical oncology, 17(1), 1994, pp. 72-76
TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL
Authors: MUSTACCHI G MILANI S PLUCHINOTTA A DEMATTEIS A RUBAGOTTI A PERROTA A BOLOGNESI A BONI C CACIOPPO C CECCHERINI R FARRIS A GAMBROSIER P GARATTINI P MAIORINO L SANTORO A SCANNI A SCHIEPPATI G SISMONDI P TRAINA A TARQUINI A ZADRO A
Citation: G. Mustacchi et al., TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL, Anticancer research, 14(5B), 1994, pp. 2197-2200
GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER
Authors: BOCCARDO F PACE M RUBAGOTTI A GUARNERI D DECENSI A ONETO F MARTORANA G GIULIANI L SELVAGGI F BATTAGLIA M DELLIPONTI U PETRACCO S CORTELLINI P ZIVERI M FERRARIS V BRUTTINI GP EPIS R COMERI G GALLO G
Citation: F. Boccardo et al., GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER, European journal of cancer, 29A(8), 1993, pp. 1088-1093
2ND-LINE HORMONOTHERAPY FOR BREAST-CANCER - USELESSNESS OF 1ST-LINE CONTINUATION
Authors: PRONZATO P RUBAGOTTI A AMOROSO D BERTELLI G QUEIROLO P SERTOLI MR ROSSO M GALLOTTI P MONZEGLIO C ROSSO R
Citation: P. Pronzato et al., 2ND-LINE HORMONOTHERAPY FOR BREAST-CANCER - USELESSNESS OF 1ST-LINE CONTINUATION, American journal of clinical oncology, 16(6), 1993, pp. 522-525
CEREBRAL METASTASES SECONDARY TO OVARIAN-CANCER - STILL AN UNUSUAL EVENT
Authors: BRUZZONE M CAMPORA E CHIARA S GIUDICI S MERLINI L SIMONI C MAMMOLITI S RUBAGOTTI A ROSSO R
Citation: M. Bruzzone et al., CEREBRAL METASTASES SECONDARY TO OVARIAN-CANCER - STILL AN UNUSUAL EVENT, Gynecologic oncology, 49(1), 1993, pp. 37-40
ANALYSIS OF TIME TO RESPONSE TO CHEMOTHERAPY IN 316 METASTATIC BREAST-CANCER PATIENTS
Authors: PRONZATO P BERTELLI G GARDIN G RUBAGOTTI A CONTE PF ROSSO R
Citation: P. Pronzato et al., ANALYSIS OF TIME TO RESPONSE TO CHEMOTHERAPY IN 316 METASTATIC BREAST-CANCER PATIENTS, Oncology, 50(6), 1993, pp. 460-465
Risultati: 1-25 | 26-26